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MOL 17145 5 phenylbutyrate; phenylacetate; valproic acid); b) synthetic benzamide derivatives (e.g., and CI-994); c) cyclic tetrapeptides (e.g., depsipeptide, trapoxin, apicidin); and d) hydroxaminic acids (SAHA, pyroxamide, TSA, oxamflatin, CHPAs; LAQ824) .
NVP-LAQ824 is a structurally novel cinnamic hydroxamic acid, which exhibits potent in vitro activity when administered at submicromolar concentrations (Atadja et al., 2004a) .
LAQ824 has been shown to induce apoptosis in multiple myeloma cell lines resistant to more conventional therapeutic agents (Catley et al., 2003) and in Bcr/Abl + human leukemia cells resistant to imatinib mesylate (Nimmanapalli et al., 2003) . LAQ824 is also active against several additional neoplastic cell types including breast (Fuino et al., 2003) , colon, non-small cell lung carcinoma, prostate cancer (Atadja et al., 2004a) and other leukemia cells (Guo et al., 2004) . In addition to its direct cytotoxic actions, LAQ824 can sensitize transformed cells to other agents.
For example, in breast cancer cells, LAQ824 depleted Her-2 mRNA and protein levels and significantly increased the lethality of trastuzumab, taxotere, gemcitabine and epothilone B (Fuino et al., 2003) . In both human SKW6.4 and Jurkat leukemia cells, LAQ824 induced an increase in the expression levels of TRAIL death receptors DR4 and DR5 and down-regulation of c-FLIP (FLICE-inhibitory protein), events which sensitize cells to subsequent TRAIL/Apo2-L exposure (Guo et al., 2004) .
Western Blot Analysis. Whole cell-pellets were washed twice in PBS, resuspended in PBS, and lysed by the addition of one volume of loading buffer (InVitrogen), as previously described (Almenara et al., 2002) . 30 µg of total proteins per point were separated by 4-12% Bis-Tris NuPAge precast gel system (Invitrogen) and electro-blotted to nitrocellulose. After incubation with the corresponding primary and secondary antibodies, blots were developed by enhanced chemiluminesence (New England Nuclear; Boston, MA). Where indicated, blots were stripped and reprobed with antibodies directed against actin. Cytosolic proteins were obtained by employing a previously described technique (Almenara et al., 2002) where the S-100, or cytosolic fraction, was prepared as described with minor modifications. For each condition, 30 µg of the S-100 fraction was loaded on the gel, and probed with the corresponding antibody. Real-Time Reverse Transcriptase-Polymerase Chain Reaction. Experiments were performed employing the ABI Prism® 7900 Sequence Detection System (Applied Biosystems, Foster City, CA) ) using the TaqMan® One
Antibodies for
Step PCR Master Mix Reagents Kit (P/N: 4309169) as described previously .
Statistical analysis. The significance of differences between experimental conditions was determined using the student's T-test for unpaired observations. To assess the interaction between agents, Median Dose Analysis (Maggio et al., 2004) was used with a commercially available software program (CalcuSyn; Biosoft, Ferguson, MO). The combination index (CI) was calculated for a 2-drug combination involving a fixed concentration ratio. Using these methods, CI values less than 1.0 indicate a synergistic interaction.
RESULTS

LAQ824
induces concentration-dependent growth arrest or cell death in human leukemia cells. While concentrations of LAQ824 ≤ 10nM had no effect on the number of cells compared to controls, exposure of to 30 nM to 75 nM LAQ824 induced partial to essentially complete cell growth inhibition respectively ( Figure 1A) . A marked increase in apoptosis was noted at LAQ824 concentrations ≥ 50 nM, with maximal effects observed following 48 hr exposure to 75 nM LAQ824. In contrast, LAQ824 concentrations ≤ 30 nM resulted in minimal toxicity ( Figure 1B) . A clear increase in the percentage of dead cells 24 hr after treatment with 75 nM LAQ82 was noted (data not shown), which correlated with cleavage/activation of Bid, caspases-3 and -8 and PARP degradation ( Figure 1C ). Results in Jurkat T-human lymphoblastic leukemia cells were similar i.e., cell growth inhibition at lower drug concentrations (20nM) and cell death at higher LAQ824 concentrations (50nM; data not shown).
This article has not been copyedited and formatted. The final version may differ from this version. hr (57.4 ± 2.6 vs. 41.2 ± 2.1%; P < 0.01), a decline in the S-phase fraction (31.9 ± 1.4 vs. 46.8 ± 2.4%; P < 0.01) and no changes in the G 2 /M population. In contrast, G 0 /G 1 arrest was not readily apparent in cells exposed to 75 nM LAQ824, as the large majority of cells were apoptotic by 48
hr. Notably, cells exposed to a lethal LAQ824 concentration displayed a large accumulation in G 2 M at 24 h (e.g., 39.5 ± 1.8 %), whereas this was not observed in cells exposed to 30 nM LAQ824 (data not shown). Western blot analysis revealed a robust concentration-dependent increase of the CDK-inhibitor p21 WAF1/CIP1 accompanied by increased levels of the hypophosphorylated forms of pRb ( Figure 1D ). Bands corresponding to pRb cleavage fragments were also noted, particularly at higher LAQ824 concentrations. Significantly, 30 nM LAQ824
induced a pronounced increase in the expression of the maturation markers CD11a and CD11b, whereas no changes were observed in cells exposed to 75 nM LAQ824 (Fig. 1E ). Both differentiation and apoptosis may limit colony formation; furthermore, the extent of apoptosis does not necessarily correlate with loss of clonogenicity (Yin and Schimke, 1995) . Analysis of clonogenic survival showed a marked reduction in clonogenicity in cells exposed to 30nM LAQ824 (i.e., from 28.3 to 21.3 % of controls for 24 or 72h exposure intervals respectively), effects that were more pronounced in cells treated with 75 nM LAQ824 (i.e., 3.5 or 0.04% of control values for 24 or 72h exposure intervals respectively; Fig. 1F ). Thus, despite exerting similar effects on p21 WAF1/CIP1 and pRb, the antiproliferative activity of a low concentration of LAQ824 stems primarily from cell cycle arrest in G 0 /G 1 and cellular maturation, whereas higher LAQ824 concentrations largely reflect caspase activation and apoptosis.
LAQ824-induced cell death does not involve activation of the extrinsic, receptormediated apoptotic pathway in U937 cells. Recently, LAQ824 has been shown to enhance the This article has not been copyedited and formatted. The final version may differ from this version. LAQ824-induced lethality was blocked by the anti-TRAIL antibody in Jurkat cells (Fig. 2A) following exposure to 75 nM LAQ824, whereas effects were much less pronounced in cells exposed to 30 nM LAQ824 (Fig. 3B) . Furthermore, exposure to 75 nM LAQ824 for 48 hr resulted in a Bcl-2 cleavage product, which has been associated with pro-apoptotic activity (Cheng et al., 1997) , and down-regulation of Bcl-xL and Mcl-1 (Fig. 3C) . Levels of XIAP were markedly reduced after 24 h of drug exposure as well and essentially absent by 48 h.
Furthermore, ectopic expression of either Bcl-2 or Bcl-xL (Rosato et al., 2003a) significantly protected U937 cells from LAQ824-mediated lethality at both 24 and 48 hr (P < 0.01; Figure   This article has not been copyedited and formatted. The final version may differ from this version. (Ruefli et al., 2001; Rosato et al., 2003b; Kurita-Ochiai et al., 2003) . Consequently, ROS levels were monitored in U937 and Jurkat cells exposed to 30 or 75 nM LAQ824. Exposure to either 30 or 75 nM LAQ824 for 2 hr induced similar increments in ROS levels in U937 cells (Fig 4A) . However, down-regulation were essentially abrogated by NAC, suggesting these were secondary, caspasedependent events. In contrast, XIAP expression was only modestly restored by NAC. The finding that both 30 and 75 nM LAQ824 concentrations induced a similar increase in ROS levels suggests that this event may be necessary but not sufficient for LAQ824-mediated lethality.
This article has not been copyedited and formatted. The final version may differ from this version. Figure 5A ). The presence of an XIAP cleavage fragment was also detected at later intervals ( Fig. 5A ), which may explain the partial restoration of protein levels by NAC (Fig. 4C ). In contrast, 30 nM LAQ824 had no effect on XIAP expression. XIAP antiapoptotic activity is exerted in part by blocking the actions of caspases 3, -7 and -9 (Deveraux et al., 1998) . Consistently, 75 nM LAQ824-mediated XIAP down-regulation correlated closely with activation of caspases 9, -3 and -7, whereas no activation was observed in cells exposed to 30 nM LAQ824. Enforced expression of XIAP (Datta et al., 2000) significantly blocked LAQ824-induced lethality at the 24 and 48-hr intervals (P < 0.02), suggesting that XIAP down-regulation plays an important functional role in LAQ824 lethality. LAQ824 effects on the transcriptional regulation of XIAP were then examined employing real time RT-PCR analysis ( Figure 5C ). LAQ824 resulted in pronounced transcriptional inhibition of XIAP gene expression, i.e. approximately 50% after 24 hours and 90% after 36-48 hours ( Figure 5C ). Moreover, levels of XIAP mRNA were only partially restored by blocking apoptosis with NAC, further demonstrating that LAQ824-induced XIAP mRNA down-regulation does not solely reflect a secondary, apoptosis-mediated event. In contrast, 30nM LAQ824 had no effect on XIAP expression at either the protein ( cleavage fragment as previously reported (Weng et al., 2005) , which was detectable after 24 hours exposure to LAQ824 (Fig. 6A ). Subsequently, U937 cells stably expressing either the empty vector (U937/pCEP) or Mcl-1 (U937/Mcl-1) cDNAs were exposed to LAQ824 75 nM for 24-48 hours. As shown in Fig. 6B , U937/Mcl-1 cells displayed a significant reduction in the extent of apoptosis induced by 75 nM LAQ824 (Fig. 6B ) which was also reflected by reduced activation of caspases 3, -7 and -9, and PARP degradation (Fig. 6C) . Together, these results suggest that down-regulation of both antiapoptotic proteins through either transcriptional (e.g., XIAP) or primarily caspase-dependent mechanisms (e.g., Mcl-1) plays a significant role in the disparate apoptotic responses of U937 cells to low (30 nM) versus high (75 nM) LAQ824
concentrations.
Exposure of U937 cells to LAQ824 induces a dramatic increase in the level of the
pro-apoptotic lipid second messenger ceramide. Because ceramide has been implicated in apoptosis induction in human leukemia cells (Jarvis et al., 1994; Kurita-Ochiai et al., 2003) , U937 and Jurkat cells were treated with LAQ824 (U937: 30 nM and 75 nM; Jurkat: 50 nM) for various intervals, after which ceramide levels were monitored. As shown in Figure 7A , lethal concentrations of LAQ824 induced significant increases in ceramide levels in both U937 and Jurkat cells which were ~ 5-fold higher than controls at 24 h and ~ 15-fold higher after 48 hr. In contrast, 30 nM LAQ824 only minimally increased ceramide levels ( Figure 7A ), raising the possibility differential increases in ceramide levels may also contribute to the disparate effects of low versus high drug concentrations.
Generation of ceramide may proceed from either de novo synthesis or hydrolysis of sphingomyelin (Pettus et al., 2002) . Consequently, U937 cells were co-incubated with inhibitors targeting these pathways at different points. The de novo synthesis inhibitors fumonisin B1 and This article has not been copyedited and formatted. The final version may differ from this version. at 48 hr; P < 0.01; Figure 7B ), suggesting that LAQ824-induced ceramide generation through the hydrolysis of sphingomyelin contributes functionally to the lethal effects of high concentrations of LAQ824. Finally, blockade of LAQ824-induced ROS by NAC essentially abrogated ceramide generation ( Figure 7C ), indicating that LAQ824-induced ROS generation leads to the acid sphingomyelinase generation of ceramide, and that the latter event represents an important functional mediator of LAQ824-induced lethality.
DISCUSSION
Whereas previous studies have demonstrated that HDACIs can induce differentiation and/or apoptosis in human leukemia cells (Vrana et al., 1999; Rosato et al., 2001; Rosato et al., 2003b) , the factors determining which of these alternative cell fates predominates remain largely unknown. In the case of LAQ824, the present results demonstrate that low concentrations of the drug led to cell cycle arrest at G 0 /G 1 , followed by cellular maturation, whereas higher concentrations induced G 2 /M arrest accompanied by pronounced mitochondrial injury and apoptosis. These findings are consistent with previous reports of HDACI-mediated tumor cell G 2 M arrest and subsequent death in mitosis due to an aberrant G 2 checkpoint (Qiu et al., 2000) . is evidence that in leukemia cells, these events are mutually exclusive (Selvakumaran et al., 1994) . It is therefore likely that when administered above threshold levels, LAQ824 triggers multiple events which culminate in apoptosis and prevent engagement of a differentiation program. It is important to note that while differentiation-induction by low LAQ824
concentrations resulted in a marked loss of clonogenic potential, high concentrations of LAQ824
were significantly more inhibitory, reflecting the pronounced increase in apoptosis.
Recent studies have highlighted the role that the extrinsic apoptotic pathway plays in and ceramide production has been characterized in several models including U937 cells exposed to daunorubicin and rat primary astrocytes (Mansat-de Mas et al., 1999) . It is unclear at present why increases in ROS induced by low LAQ824 concentrations failed to increase ceramide levels, while higher LAQ824 concentrations did so. One speculative possibility is that high concentrations of LAQ824 might interfere with the function of chaperones such as Hsp90
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